SCHEMBL20107926

SCHEMBL20107926

CCCCOc1cc(Br)c(F)cc1C(=O)Nc1c(F)cccc1Cl

nearest known ligand 0.53

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
DHODH Q02127 16/20 0.53
HTT P42858 1/20 0.50
RECQL P46063 1/20 0.50
PDE4D Q08499 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20107607 0.88 DHODH (0.47) DHODHHTTRECQLPDE4D
SCHEMBL21471180 0.86 DHODH (0.52) DHODHHTTRECQLPDE4D
SCHEMBL25910497 0.85 DHODH (0.52) DHODH
SCHEMBL20107685 0.85 DHODH (0.51) DHODH
SCHEMBL20107924 0.84 DHODH (0.62) DHODH
SCHEMBL28823374 0.84 DHODH (0.62) DHODH
SCHEMBL29816745 0.84 DHODH (0.62) DHODH
SCHEMBL20107888 0.81 DHODH (0.47) DHODHHTT
SCHEMBL20107686 0.79 DHODH (0.75) DHODH
SCHEMBL21435672 0.79 DHODH (0.75) DHODH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3532468-B1 2,4,5-TRISUBSTITUTED 1,2,4-TRIAZOLONES USEFUL AS INHIBITORS OF DHODH BAYER AG (DE) 2022-03-23 EP disclosed
EP-3553052-A1 5-OXO-4,5-DIHYDRO-1H-1,2,4-TRIAZOL DERIVATIVES FOR THE TREATMENT OF CANCER Bayer AG (DE) 2019-10-16 EP disclosed
EP-3553052-A1 5-OXO-4,5-DIHYDRO-1H-1,2,4-TRIAZOL DERIVATIVES FOR THE TREATMENT OF CANCER Bayer AG (DE) 2019-10-16 EP disclosed
WO-2018077923-A1 2,4,5-TRISUBSTITUTED 1,2,4-TRIAZOLONES USEFUL AS INHIBITORS OF DHODH BAYER AKTIENGESELLSCHAFT (DE) 2018-05-03 WO disclosed